You are here

Article info

Article menu
Download PDFPDF
Editorial commentary
Oral laquinimod for multiple sclerosis: beyond the anti-inflammatory effect

Authors

  1. Correspondence to Dr Carmen Tur, Multiple Sclerosis Centre of Catalonia (Cemcat), Neurology-Neuroimmunology Department, Vall d'Hebron University Hospital, Barcelona 08035, Spain; ctur{at}cem-cat.org
View Full Text

Citation

Tur C
Oral laquinimod for multiple sclerosis: beyond the anti-inflammatory effect
Journal of Neurology, Neurosurgery & Psychiatry 2014;85:832.

Publication history

  • Received August 15, 2013
  • Revised August 18, 2013
  • Accepted August 20, 2013
  • First published September 17, 2013.
Online issue publication 
April 13, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions